10-Q Filing

CARDINAL HEALTH INC CIK: 721371 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0000721371-16-000207`
Period End Date	20151231
Filing Date	20160202
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	cah-20151231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 88 Cash Flow Statement 76 Comprehensive Income 28

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Preferred shares, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred shares, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred shares, Authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, Authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred shares, Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Common shares, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Common shares, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Common shares, Authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, Authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.87B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.88B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.32B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.62B	USD	Point-in-time
Common shares, Issued	`CommonStockSharesIssued`	364.00M	shares	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$6.98B	USD	Point-in-time
Common shares, Issued	`CommonStockSharesIssued`	364.00M	shares	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$6.52B	USD	Point-in-time
Inventories, net	`InventoryNet`	$9.21B	USD	Point-in-time
Common shares in treasury	`TreasuryStockShares`	36.00M	shares	Point-in-time
Inventories, net	`InventoryNet`	$11.01B	USD	Point-in-time
Common shares in treasury	`TreasuryStockShares`	34.00M	shares	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$1.40B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$1.52B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$21.83B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$21.75B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.65B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.51B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$6.02B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$9.11B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$914.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$866.00M	USD	Point-in-time
Total assets	`Assets`	$30.14B	USD	Point-in-time
Total assets	`Assets`	$33.51B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$16.92B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$14.37B	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$281.00M	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$354.00M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$1.61B	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.59B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.88B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.24B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$5.21B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$5.17B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$1.43B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$2.61B	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	-	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$120.00M	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized755 million shares, Issued364 million shares at December 31, 2015 and June 30, 2015	`CommonStockValue`	$3.00B	USD	Point-in-time
Authorized755 million shares, Issued364 million shares at December 31, 2015 and June 30, 2015	`CommonStockValue`	$2.97B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$5.52B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$5.97B	USD	Point-in-time
Common shares in treasury, at cost: 34 million shares and 36 million shares at December 31, 2015 and June 30, 2015, respectively	`TreasuryStockValue`	$2.14B	USD	Point-in-time
Common shares in treasury, at cost: 34 million shares and 36 million shares at December 31, 2015 and June 30, 2015, respectively	`TreasuryStockValue`	$2.25B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-97.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-23.00M	USD	Point-in-time
Total Cardinal Health, Inc. shareholder's equity	`StockholdersEquity`	$6.71B	USD	Point-in-time
Total Cardinal Health, Inc. shareholder's equity	`StockholdersEquity`	$6.26B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$17.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	-	USD	Point-in-time
Total shareholder's equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.73B	USD	Point-in-time
Total shareholder's equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.26B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests, and shareholders equity	`LiabilitiesAndStockholdersEquity`	$33.51B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests, and shareholders equity	`LiabilitiesAndStockholdersEquity`	$30.14B	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$59.50B	USD	2 Qtrs
Revenue	`Revenues`	$49.61B	USD	2 Qtrs
Revenue	`Revenues`	$25.54B	USD	1 Quarter
Revenue	`Revenues`	$31.45B	USD	1 Quarter
Cost of products sold	`CostOfGoodsSold`	$46.81B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsSold`	$29.84B	USD	1 Quarter
Cost of products sold	`CostOfGoodsSold`	$24.08B	USD	1 Quarter
Cost of products sold	`CostOfGoodsSold`	$56.31B	USD	2 Qtrs
Gross margin	`GrossProfit`	$1.45B	USD	1 Quarter
Gross margin	`GrossProfit`	$1.61B	USD	1 Quarter
Gross margin	`GrossProfit`	$3.19B	USD	2 Qtrs
Gross margin	`GrossProfit`	$2.79B	USD	2 Qtrs
Distribution, selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$922.00M	USD	1 Quarter
Distribution, selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$815.00M	USD	1 Quarter
Distribution, selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.76B	USD	2 Qtrs
Distribution, selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.59B	USD	2 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$7.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$14.00M	USD	2 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$26.00M	USD	2 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$2.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$219.00M	USD	2 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$112.00M	USD	2 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$114.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$60.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$18.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-17.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-17.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$18.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-44.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$9.00M	USD	2 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-72.00M	USD	2 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$9.00M	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$1.18B	USD	2 Qtrs
Operating earnings	`OperatingIncomeLoss`	$546.00M	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$563.00M	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$1.01B	USD	2 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$1.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$-6.00M	USD	2 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$4.00M	USD	2 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$2.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$36.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$45.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$90.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$70.00M	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-60.00M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-60.00M	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$520.00M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.09B	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$886.00M	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$451.00M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$331.00M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$194.00M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$377.00M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$162.00M	USD	1 Quarter
Net Earnings	`ProfitLoss`	$710.00M	USD	2 Qtrs
Net Earnings	`ProfitLoss`	$289.00M	USD	1 Quarter
Net Earnings	`ProfitLoss`	$326.00M	USD	1 Quarter
Net Earnings	`ProfitLoss`	$555.00M	USD	2 Qtrs
Net earnings attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Net earnings attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net earnings attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net earnings attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$326.00M	USD	1 Quarter
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$555.00M	USD	2 Qtrs
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$289.00M	USD	1 Quarter
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$709.00M	USD	2 Qtrs
Net basic earnings per common share (in dollars per share)	`EarningsPerShareBasic`	$2.16	USD	2 Qtrs
Net basic earnings per common share (in dollars per share)	`EarningsPerShareBasic`	$0.99	USD	1 Quarter
Net basic earnings per common share (in dollars per share)	`EarningsPerShareBasic`	$0.87	USD	1 Quarter
Net basic earnings per common share (in dollars per share)	`EarningsPerShareBasic`	$1.66	USD	2 Qtrs
Net diluted earnings per common share (in dollars per share)	`EarningsPerShareDiluted`	$2.14	USD	2 Qtrs
Net diluted earnings per common share (in dollars per share)	`EarningsPerShareDiluted`	$1.65	USD	2 Qtrs
Net diluted earnings per common share (in dollars per share)	`EarningsPerShareDiluted`	$0.98	USD	1 Quarter
Net diluted earnings per common share (in dollars per share)	`EarningsPerShareDiluted`	$0.86	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	329.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	333.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	329.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	331.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	332.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	332.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	334.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	337.00M	shares	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.77	USD	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.69	USD	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.39	USD	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.34	USD	1 Quarter

Cash Flow Statement 76 line items

Line Item	Tag	Value	Unit	Period
Net Earnings	`ProfitLoss`	$710.00M	USD	2 Qtrs
Net Earnings	`ProfitLoss`	$289.00M	USD	1 Quarter
Net Earnings	`ProfitLoss`	$326.00M	USD	1 Quarter
Net Earnings	`ProfitLoss`	$555.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$306.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$220.00M	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-60.00M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-60.00M	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Gain on sale of other investments	`GainOnSaleOfInvestments`	-	USD	2 Qtrs
Gain on sale of other investments	`GainOnSaleOfInvestments`	$5.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$18.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-17.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-17.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$18.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$56.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$53.00M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$35.00M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$26.00M	USD	2 Qtrs
Change in fair value of contingent consideration obligation	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	-	USD	2 Qtrs
Change in fair value of contingent consideration obligation	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-14.00M	USD	2 Qtrs
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$291.00M	USD	2 Qtrs
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$393.00M	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$1.56B	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$1.14B	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.43B	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.44B	USD	2 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-113.00M	USD	2 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$172.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.41B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.01B	USD	2 Qtrs
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$86.00M	USD	2 Qtrs
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.28B	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$83.00M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$175.00M	USD	2 Qtrs
Purchase of available-for-sale securities and other investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$88.00M	USD	2 Qtrs
Purchase of available-for-sale securities and other investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$107.00M	USD	2 Qtrs
Proceeds from sale of available-for-sale securities and other investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$107.00M	USD	2 Qtrs
Proceeds from sale of available-for-sale securities and other investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$57.00M	USD	2 Qtrs
Proceeds from maturities of available-for-sale securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$19.00M	USD	2 Qtrs
Proceeds from maturities of available-for-sale securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$16.00M	USD	2 Qtrs
Proceeds from divestitures and disposal of held for sale assets	`Proceedsfromdivestituresanddisposalofheldforsaleassets`	-	USD	2 Qtrs
Proceeds from divestitures and disposal of held for sale assets	`Proceedsfromdivestituresanddisposalofheldforsaleassets`	$53.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.47B	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-100.00M	USD	2 Qtrs
Payment of contingent consideration obligation	`PaymentofContingentConsideration`	-	USD	2 Qtrs
Payment of contingent consideration obligation	`PaymentofContingentConsideration`	$23.00M	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$-18.00M	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$39.00M	USD	2 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$4.00M	USD	2 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$1.22B	USD	2 Qtrs
Proceeds from long-term obligations, net of issuance costs	`ProceedsFromDebtNetOfIssuanceCosts`	$1.18B	USD	2 Qtrs
Proceeds from long-term obligations, net of issuance costs	`ProceedsFromDebtNetOfIssuanceCosts`	-	USD	2 Qtrs
Net proceeds/(tax withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-7.00M	USD	2 Qtrs
Net proceeds/(tax withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$35.00M	USD	2 Qtrs
Tax proceeds from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$42.00M	USD	2 Qtrs
Tax proceeds from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$32.00M	USD	2 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$259.00M	USD	2 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$233.00M	USD	2 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$686.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-898.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-222.00M	USD	2 Qtrs
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	-	USD	2 Qtrs
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-10.00M	USD	2 Qtrs
Net increase/(decrease) in cash and equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$16.00M	USD	2 Qtrs
Net increase/(decrease) in cash and equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.29B	USD	2 Qtrs
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.87B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.88B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.32B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.62B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.87B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.88B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.32B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.62B	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net Earnings	`ProfitLoss`	$710.00M	USD	2 Qtrs
Net Earnings	`ProfitLoss`	$289.00M	USD	1 Quarter
Net Earnings	`ProfitLoss`	$326.00M	USD	1 Quarter
Net Earnings	`ProfitLoss`	$555.00M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-64.00M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-73.00M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-40.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-28.00M	USD	1 Quarter
Net unrealized loss on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-1.00M	USD	1 Quarter
Net unrealized loss on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-9.00M	USD	2 Qtrs
Net unrealized loss on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-9.00M	USD	1 Quarter
Net unrealized loss on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-1.00M	USD	2 Qtrs
Total other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-73.00M	USD	2 Qtrs
Total other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-29.00M	USD	1 Quarter
Total other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-74.00M	USD	2 Qtrs
Total other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-49.00M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$482.00M	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$240.00M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$636.00M	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$297.00M	USD	1 Quarter
Comprehensive income/(loss), net of tax attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Comprehensive income/(loss), net of tax attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Comprehensive income/(loss), net of tax attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Comprehensive income/(loss), net of tax attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$297.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$240.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$635.00M	USD	2 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$482.00M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.